: Faslodex. ?  »
|
-

I.M

Solution For Injection

Faslodex is indicated for the treatment of postmenopausal women with oestrogen receptor positive, locally advanced or metastatic breast cancer for disease relapse on or after adjuvant antioestrogen therapy or disease progression on therapy with an antioestrogen.06/06/2010 ???©? ??©???? ??©?? ????? The recommended dose is 500 mg at intervals of one month, with an additional 500 mg dose given two weeks after the initial dose.

132 67 31114 01

Astra Zeneca Uk Limited

03/2010 - 03/2020

.
, .
.
/
Fulvestrant 250 MG / 5 ML
Syringe prefilled glass type i 1 x 5 ML 48

*

*

 

.

. :  »
 
" !
 
555
`